Search for: "Merz Pharma GmbH &
Co. KGaA"
Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
9 Apr 7:52 am
... - what do you think? (IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference
on SPC Regulation interpretation from ... slow down fast tracked patent dispute: Synthon BV v Merz Pharma GmbH & Co KGaA (The SPC Blog) (PatLit) (IPKat) Cardene
(Nicardipine) - US: District ... : Sustained release OxyContin patent sustained: Napp Pharmaceutical Holdings Ltd v ratiopharm GmbH/Napp
Pharmaceutical Holdings Ltd v Sandoz Ltd (Hal Wegner) (IPKat) ( ...
31 Oct, 2006 5:46 pm
... dies LexisNexis Butterworths' subscription service was first off the mark with Merz Pharma
GmbH and Co KGaA v Allergan Inc, a Patents Court decision of Mr ... neurotoxin component of
Botulinium type A, B, C, D, E, F or G'. Merz applied to have the patent revoked on the ground (among others) that the patent disclosed
additional ... disclosed, both explicitly and implicitly, by the original application. Kitchin J allowed Merz's claim and ruled that the BOTOX
patent was invalid. In his view * It was long ...
13 Feb, 2008 6:19 pm
... of Orange Book-listed U.S. Patent No. 5,061,703. Plaintiff Forest Labs. Holdings, Ltd., is an Irish company based in Bermuda; plaintiffs Merz Pharma GmbH & Co. KGaA and Merz Pharma GmbH are
German companies. Also according to the complaint, defendant Lupin Pharmaceuticals, ... Ltd., an Indian company based in Mumbai. Lupin Ltd. allegedly submitted, through its agent Lupin
Pharma, an Abbreviated New Drug Application No. 90-051 to the FDA for approval to market generic Namenda®. It ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog
Search | Technorati | Google | MSN | Yahoo!